Fuse Oncology, ACRO Partner to Integrate Clinical Pathways Platform
Strategic agreement will standardize clinical pathways through ACROPath® BOONE, N.C., March 13, 2025 /PRNewswire/ — Fuse Oncology, an oncology healthcare software…
Healthplans.ai Emerges from Stealth Mode to Revolutionize Health Plans
GREENWOOD VILLAGE, Colo., March 13, 2025 /PRNewswire/ — Healthplans.ai offers a comprehensive suite of AI-empowered and platform agnostic solutions designed…
ANDREW PHUNG HOSTS THE SIZZLING NEW CANADIAN ORIGINAL SERIES, BIG BURGER BATTLE, PREMIERING APRIL 21 ON FLAVOUR NETWORK
Burger Scholar and Restaurateur George Motz and Renowned Chef Connie DeSousa Fire Up the Judging Panel This Season’s Grill-Ready Sponsors…
Claremont Insurance Services Partners with HealthNet to Expand Small Group Offerings
CONCORD, Calif., March 13, 2025 /PRNewswire/ — Claremont Insurance Services, a leading general agent serving employee benefits brokers throughout California,…
Window World announces partnership with Folds of Honor
NORTH WILKESBORO, N.C., March 13, 2025 /PRNewswire/ — Window World has long been conscious of its responsibility to respect and acknowledge…
Canadian Investment Regulatory Organization Trading Halt – AFM
VANCOUVER, BC, March 13, 2025 /CNW/ – The following issues have been halted by CIRO Company: Alphamin Resources Corp. TSX-Venture…
Small Axe Delivers $800K in Savings for AI Computing Company Through Strategic Data Center Migration
SCOTTSDALE, Ariz., March 13, 2025 /PRNewswire/ — Technology evaluation firm Small Axe has completed a high-stakes data center migration project for…
WuXi XDC Wins Multiple Awards at Asia-Pacific Biopharma Excellence Awards 2025
SHANGHAI, March 13, 2025 /PRNewswire/ — WuXi XDC Cayman Inc. (“WuXi XDC”, or the “Company”, stock code: 2268.HK), a leading…
FROM BAKU TO BELÉM: MALAYSIA’S COP29 LEADERSHIP DRIVING REGIONAL AND GLOBAL CLIMATE ACTION
BAKU, Azerbaijan, March 13, 2025 /PRNewswire/ — As the world grapples with the ever-evolving challenges of climate change, Malaysia remains…
BioCity Biopharmaceutics Co., Ltd. Announces Clinical Collaboration to Evaluate BC3195 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Locally Advanced or Metastatic Solid Tumors
SHANGHAI, March 13, 2025 /PRNewswire/ — BioCity Biopharmaceutics Co., Ltd., a clinical-stage biopharmaceutical company, today announced that it has entered into…
↑